CTLA-4-Antigen

Search results for CTLA-4-Antigen

Found 468 articles. Showing from 1 to 10.

Clinical cancer research (2012-04-04)
CTLA-4 blockade with ipilimumab: long-term follow-up of 177 patients with metastatic melanoma.

Clinical cancer research (2011-11-17)
Ipilimumab: an anti-CTLA-4 antibody for metastatic melanoma.

Journal of immunology (2012-05-21)
IL-10+ CTLA-4+ Th2 inhibitory cells form in a Foxp3-independent, IL-2-dependent manner from Th2 effectors during chronic inflammation.

Journal of immunology (2012-09-05)
Diversity of antigen-specific responses induced in vivo with CTLA-4 blockade in prostate cancer patients.

Iranian journal of immunology (2012-10-01)
Strong Association of CTLA-4 Variation (CT60A/G) and CTLA-4 Haplotypes with Predisposition of Iranians to Head and Neck Cancer.

British journal of cancer (2013-03-19)
Exploiting CTLA-4, PD-1 and PD-L1 to reactivate the host immune response against cancer.

The Journal of experimental medicine (2004-03-16)
CD152 (CTLA-4) determines the unequal resistance of Th1 and Th2 cells against activation-induced cell death by a mechanism requiring PI3 kinase function.

Chang Gung medical journal (2008-04-18)
Immune intervention with monoclonal antibodies targeting CD152 (CTLA-4) for autoimmune and malignant diseases.

Journal of immunology (2012-11-14)
Human prostate tumor antigen-specific CD8+ regulatory T cells are inhibited by CTLA-4 or IL-35 blockade.

Immunity (1999-11-23)
CTLA-4 blockade reverses CD8+ T cell tolerance to tumor by a CD4+ T cell- and IL-2-dependent mechanism.

« Previous
1
2
3
4
5
6
7
8
9
10
11
Next »

Filters

Journals

Categories

Subjects

Year of publication

Español | English

© Galenicom 1999-2013